Lokavant, a clinical trial intelligence platform, has strengthened its team with the appointment of three new Advisory Board members and a new executive.

The Advisory Board includes industry leaders like Pfizer’s Head of Predictive Analytics, Jonathan Crowther, who provide insights into the data and analytics needs of clinical trial sponsors and contract research organizations (CROs).

Aaron Mackey, PhD, a former Covance executive, joins as senior vice president of AI and data science. Mackey brings expertise in artificial intelligence (AI) and data science to Lokavant, instrumental in advancing its technology and deriving novel insights.

Lokavant’s Clinical Intelligence Platform utilizes data and predictive analytics to optimize clinical research outcomes. Despite the growing role of AI and increased data availability, life sciences face challenges harnessing data effectively for practical AI applications.

Lokavant’s platform addresses this issue by aggregating and harmonizing data from multiple sources, enabling data scientists to analyze it effectively. This facilitates the identification of patterns and insights, empowering sponsors and CROs to make proactive decisions.

Lokavant’s platform and predictive analytics address the challenges in the clinical research industry, leveraging data and AI to improve efficiency and accelerate the delivery of new therapies to patients.

Source link: http://www.businesswire.com/news/home/20240507584278/en/Lokavant-Expands-Team-to-Drive-Strategic-Direction-of-AI-Based-Clinical-Trial-Feasibility-Solution

author avatar
Ferry Darma
Ferry Darma is Director of Media Relations at The Clinical Trial Vanguard. Ferry, a computer data scientist, focuses on the latest clinical trial industry news and trends.